作者
Kenji Oki, Kiminori Yamane
发表日期
2007/6/1
来源
Expert Opinion on Pharmacotherapy
卷号
8
期号
9
页码范围
1283-1291
出版商
Taylor & Francis
简介
Adrenal insufficiency is a life-threatening disorder. In the treatment of adrenal insufficiency, it is essential to administer the optimal medication at the optimal dose. Glucocorticoids are the main therapeutic approach in all forms of adrenal insufficiency. The recommended protocol for maintenance therapy is 15 – 25 mg of hydrocortisone, divided into two or three separate doses. Patients with primary adrenal insufficiency generally receive mineralocorticoid replacement comprised of fludrocortisone 0.05 – 0.2 mg/day. Recently, dehydroepiandrosterone has been proposed as a new therapeutic approach, despite the lack of strong evidence for beneficial effects. Additional glucocorticoid supplementation should be administered in stressful states. During critical illness, inadequate or no temporary increase in the dose of the replacement glucocorticoid can lead to acute adrenal failure. When acute adrenal failure occurs, it …
引用总数
200720082009201020112012201320142015201620172018201920202021202220232024122714222111
学术搜索中的文章
K Oki, K Yamane - Expert Opinion on Pharmacotherapy, 2007